N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. 1994

A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
Dipartimento di Genetica e Microbiologia, Università di Pavia, Italy.

UI MeSH Term Description Entries
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017313 Fenretinide A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. 4-HPR,4-Hydroxyphenylretinamide,Fenretinide, 13-cis-Isomer,Fenretinimide,MCN-R-1967,N-(4-Hydroxyphenyl)-trans-Retinamide,N-(4-Hydroxyphenyl)retinamide,13-cis-Isomer Fenretinide,4 Hydroxyphenylretinamide,Fenretinide, 13 cis Isomer,MCN R 1967,MCNR1967

Related Publications

A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
November 1994, International journal of cancer,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
October 1996, Cancer letters,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
September 1999, International journal of oncology,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
February 1995, Cancer research,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
May 2000, Experimental cell research,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
August 1997, Journal of the National Cancer Institute,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
September 2011, Neuroscience letters,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
August 2008, Brain research,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
August 2011, Cancer chemotherapy and pharmacology,
A Mariotti, and E Marcora, and G Bunone, and A Costa, and U Veronesi, and M A Pierotti, and G Della Valle
September 2009, Neuroscience,
Copied contents to your clipboard!